Literature DB >> 22698074

Structural and functional impairment of the retina and optic nerve in Alzheimer's disease.

Marilita M Moschos1, Ioannis Markopoulos, Irini Chatziralli, Alexandros Rouvas, Sokratis G Papageorgiou, Ioannis Ladas, Dimitrios Vassilopoulos.   

Abstract

PURPOSE: The purpose of this study was to evaluate the macular and retinal nerve fiber layer (RNFL) thickness, and the electrical activity of the macula in patients with Alzheimer's disease (AD).
MATERIAL AND METHODS: 30 patients with AD and 30 age and sex matched healthy controls were studied. The thickness and the electrical activity of the macula were evaluated by means of optical coherence tomography (OCT) and multifocal-electroretinogram (mf-ERG).
RESULTS: Visual acuity, as well as visual fields and colour vision testing of all patients were normal. However, the mean foveal thickness was 148.50 μm (vs. 171.50 μm in the control group, p=0.001) and the RNFL thickness was 104.5 μm in the superior area (vs 123 μm in the control group, p < 0.0001) and 116.5 μm in the inferior area (vs. 138 μm in the control group, p < 0.0001) around the optic nerve. The mean P1 response density amplitude of the foveal area was 146.50 nV/deg2 (vs. 293 nV/deg2 in the control group, p < 0.0001) and the perifoveal area was 56.60 nV/deg2 (vs. 81.50 nv/deg2 in the control group, p < 0.001).
CONCLUSION: Our study showed that in patients with AD, even without visual failure there was a decrease in macular and RNFL thickness, as well as a decrease of the electrical activity of the macula.

Entities:  

Mesh:

Year:  2012        PMID: 22698074     DOI: 10.2174/156720512802455340

Source DB:  PubMed          Journal:  Curr Alzheimer Res        ISSN: 1567-2050            Impact factor:   3.498


  50 in total

Review 1.  At the interface of sensory and motor dysfunctions and Alzheimer's disease.

Authors:  Mark W Albers; Grover C Gilmore; Jeffrey Kaye; Claire Murphy; Arthur Wingfield; David A Bennett; Adam L Boxer; Aron S Buchman; Karen J Cruickshanks; Davangere P Devanand; Charles J Duffy; Christine M Gall; George A Gates; Ann-Charlotte Granholm; Takao Hensch; Roee Holtzer; Bradley T Hyman; Frank R Lin; Ann C McKee; John C Morris; Ronald C Petersen; Lisa C Silbert; Robert G Struble; John Q Trojanowski; Joe Verghese; Donald A Wilson; Shunbin Xu; Li I Zhang
Journal:  Alzheimers Dement       Date:  2014-07-09       Impact factor: 21.566

2.  Characteristics of morphologic macular abnormalities in neuroimmunology practice.

Authors:  Omar Al-Louzi; Elias S Sotirchos; Angela Vidal-Jordana; Shin C Beh; Julia Button; Howard S Ying; Laura J Balcer; Elliot M Frohman; Shiv Saidha; Peter A Calabresi; Scott D Newsome
Journal:  Mult Scler       Date:  2017-11-10       Impact factor: 6.312

Review 3.  OCT: New perspectives in neuro-ophthalmology.

Authors:  Gema Rebolleda; Laura Diez-Alvarez; Alfonso Casado; Carmen Sánchez-Sánchez; Elisabet de Dompablo; Julio J González-López; Francisco J Muñoz-Negrete
Journal:  Saudi J Ophthalmol       Date:  2014-10-05

4.  Retinal amyloid pathology and proof-of-concept imaging trial in Alzheimer's disease.

Authors:  Yosef Koronyo; David Biggs; Ernesto Barron; David S Boyer; Joel A Pearlman; William J Au; Shawn J Kile; Austin Blanco; Dieu-Trang Fuchs; Adeel Ashfaq; Sally Frautschy; Gregory M Cole; Carol A Miller; David R Hinton; Steven R Verdooner; Keith L Black; Maya Koronyo-Hamaoui
Journal:  JCI Insight       Date:  2017-08-17

Review 5.  Revolution of Alzheimer Precision Neurology. Passageway of Systems Biology and Neurophysiology.

Authors:  Harald Hampel; Nicola Toschi; Claudio Babiloni; Filippo Baldacci; Keith L Black; Arun L W Bokde; René S Bun; Francesco Cacciola; Enrica Cavedo; Patrizia A Chiesa; Olivier Colliot; Cristina-Maria Coman; Bruno Dubois; Andrea Duggento; Stanley Durrleman; Maria-Teresa Ferretti; Nathalie George; Remy Genthon; Marie-Odile Habert; Karl Herholz; Yosef Koronyo; Maya Koronyo-Hamaoui; Foudil Lamari; Todd Langevin; Stéphane Lehéricy; Jean Lorenceau; Christian Neri; Robert Nisticò; Francis Nyasse-Messene; Craig Ritchie; Simone Rossi; Emiliano Santarnecchi; Olaf Sporns; Steven R Verdooner; Andrea Vergallo; Nicolas Villain; Erfan Younesi; Francesco Garaci; Simone Lista
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

6.  Spectral-Domain OCT Measurements in Alzheimer's Disease: A Systematic Review and Meta-analysis.

Authors:  Victor T T Chan; Zihan Sun; Shumin Tang; Li Jia Chen; Adrian Wong; Clement C Tham; Tien Y Wong; Christopher Chen; M Kamran Ikram; Heather E Whitson; Eleonora M Lad; Vincent C T Mok; Carol Y Cheung
Journal:  Ophthalmology       Date:  2018-08-13       Impact factor: 12.079

7.  Beta-amyloid, phospho-tau and alpha-synuclein deposits similar to those in the brain are not identified in the eyes of Alzheimer's and Parkinson's disease patients.

Authors:  Cheng-Ying Ho; Juan C Troncoso; David Knox; Walter Stark; Charles G Eberhart
Journal:  Brain Pathol       Date:  2013-06-28       Impact factor: 6.508

8.  Sporadic visual acuity loss in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT).

Authors:  Benjamin J Kim; Gui-Shuang Ying; Jiayan Huang; Nicole E Levy; Maureen G Maguire
Journal:  Am J Ophthalmol       Date:  2014-04-13       Impact factor: 5.258

9.  Using Retinal Imaging to Study Dementia.

Authors:  Victor T T Chan; Tiffany H K Tso; Fangyao Tang; Clement Tham; Vincent Mok; Christopher Chen; Tien Y Wong; Carol Y Cheung
Journal:  J Vis Exp       Date:  2017-11-06       Impact factor: 1.355

Review 10.  Alzheimer's disease: A review of its visual system neuropathology. Optical coherence tomography-a potential role as a study tool in vivo.

Authors:  J P Cunha; N Moura-Coelho; R P Proença; A Dias-Santos; J Ferreira; C Louro; A Castanheira-Dinis
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-07-04       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.